IL88262A0 - Factors associated with essential hypertension and derivatives thereof and their diagnostic and therapeutic use - Google Patents

Factors associated with essential hypertension and derivatives thereof and their diagnostic and therapeutic use

Info

Publication number
IL88262A0
IL88262A0 IL88262A IL8826288A IL88262A0 IL 88262 A0 IL88262 A0 IL 88262A0 IL 88262 A IL88262 A IL 88262A IL 8826288 A IL8826288 A IL 8826288A IL 88262 A0 IL88262 A0 IL 88262A0
Authority
IL
Israel
Prior art keywords
diagnostic
derivatives
therapeutic use
factors associated
essential hypertension
Prior art date
Application number
IL88262A
Original Assignee
Univ Washington
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Washington filed Critical Univ Washington
Publication of IL88262A0 publication Critical patent/IL88262A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C381/00—Compounds containing carbon and sulfur and having functional groups not covered by groups C07C301/00 - C07C337/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/44—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6848—Methods of protein analysis involving mass spectrometry
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2405/00—Assays, e.g. immunoassays or enzyme assays, involving lipids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • G01N2800/321—Arterial hypertension

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Cardiology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
IL88262A 1987-10-29 1988-11-02 Factors associated with essential hypertension and derivatives thereof and their diagnostic and therapeutic use IL88262A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11593487A 1987-10-29 1987-10-29
US19462988A 1988-05-16 1988-05-16

Publications (1)

Publication Number Publication Date
IL88262A0 true IL88262A0 (en) 1989-06-30

Family

ID=26813726

Family Applications (1)

Application Number Title Priority Date Filing Date
IL88262A IL88262A0 (en) 1987-10-29 1988-11-02 Factors associated with essential hypertension and derivatives thereof and their diagnostic and therapeutic use

Country Status (5)

Country Link
EP (1) EP0386140A1 (en)
JP (1) JPH03501850A (en)
AU (1) AU2812589A (en)
IL (1) IL88262A0 (en)
WO (1) WO1989003836A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5350771A (en) * 1989-03-22 1994-09-27 Peter K. T. Pang Method and treatment for hypertension using combination therapy involving exogenous calcium and calcium channel blockers
AU643685B2 (en) * 1989-03-22 1993-11-25 Peter K.T. Pang Parathyroid hypertensive factor
US5886012A (en) * 1989-03-22 1999-03-23 Peter K. T. Pang Method of treatment for disease associated with excessive PHF using combination therapy involving exogenous calcium and calcium channel blockers
AU674018B2 (en) * 1992-06-12 1996-12-05 Peter K.T. Pang Active component of parathyroid hypertensive factor
GB9301629D0 (en) * 1993-01-27 1993-03-17 Scotia Holdings Plc Formulations containing unsaturated fatty acids

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3577446A (en) * 1968-09-09 1971-05-04 American Home Prod Phosphatidylalkanolamine derivatives
US4321120A (en) * 1980-03-19 1982-03-23 Nardi Ronald V Process for detecting proteins specific to hypertension in mammals
AU559292B2 (en) * 1984-12-28 1987-03-05 Terumo Kabushiki Kaisha Polymerisable liposome-forming lipids

Also Published As

Publication number Publication date
JPH03501850A (en) 1991-04-25
EP0386140A1 (en) 1990-09-12
AU2812589A (en) 1989-05-23
WO1989003836A1 (en) 1989-05-05

Similar Documents

Publication Publication Date Title
GB2221390B (en) Niacin-containing composition and its therapeutic use
GB2214430B (en) Diathermy unit
IL78756A0 (en) Catheter and probe
IL89885A0 (en) Fibrin-collagen tissue equivalents and their production
EP0406428A4 (en) Peptide derivatives and their use
GR3003070T3 (en) Benzoxazole derivatives and preparation thereof
AR243240A1 (en) Human interleukin-3 and muteins thereof
EP0292437A3 (en) Piperidylaminotriazine derivatives and their use as stabilizers
IL90690A0 (en) Tissue equivalents and their preparation
JPS6454032A (en) Polydisilacyclobutasilazane and its preparation and use
EP0304802A3 (en) Pharmaceutical composition and the use thereof
ZA885150B (en) N-aminobutyl-n-phenylarylamide derivatives,their preparation and their application in therapy
GB8820185D0 (en) New medical use
AR243523A1 (en) Imidazopyridine derivatives, their preparation and therapeutical use
ZA899528B (en) Adenosin derivatives,their preparation and use
IL88262A0 (en) Factors associated with essential hypertension and derivatives thereof and their diagnostic and therapeutic use
EP0370115A4 (en) Catheter for diagnosis and therapy
EP0316934A3 (en) Muramyl peptide derivatives and use thereof
AU1450788A (en) Thiophene-2-carbox-amide derivatives and their pharmaceutical use
IL86796A0 (en) Peptide derivatives,their preparation and their use
AU2623088A (en) New anti-receptor peptides and therapeutic agents
IL85392A (en) 27-halo-26-methylene- ll-f28249 derivatives and parasiticidal use
HK1005735A1 (en) Perhydrothiazepine and perhydroazepine derivatives their preparation and their therapeutic use
ZA852632B (en) Perhydrothiazepine derivatives,their preparation and their therapeutic use
HK1003571A1 (en) Alkenyltetrazole derivatives their preparation and use